The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Life and death by death receptors
Open accessAbstract
Death receptors are members of the tumor necrosis factor receptor superfamily characterized by a cytoplasmic region known as the “death domain” that enables the receptors to initiate cytotoxic signals when engaged by cognate ligands. Binding to the ligand results in receptor aggregation and recruitment of adaptor proteins, which, in turn, initiates a proteolytic cascade by recruiting and activating initiator caspases 8 and 10. Death receptors were once thought to primarily induce cytotoxic signaling cascades. However, recent data indicate that they initiate multiple signaling pathways, unveiling a number of nonapoptosis‐related functions, including regulation of cell proliferation and differentiation, chemokine production, inflammatory responses, and tumor‐promoting activities. These noncytotoxic cascades are not simply a manifestation of inhibiting proapoptotic pathways but are intrinsically regulated by adaptor protein and receptor internalization processes. Insights into these various death receptor signaling pathways provide new therapeutic strategies targeting these receptors in pathophysiological processes.—Guicciardi, M.E., Gores, G.J. Life and death by death receptors. FASEB J. 23, 1625–1637 (2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
The TNF and TNF Receptor Superfamilies
Locksley, R. M., Killeen, N., & Lenardo, M. J. (2001) · Cell · doi:10.1016/s0092-8674(01)00237-9 · Cited by 3,650
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Suppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Inhibition of death receptor signals by cellular FLIP
Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,563
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
Pan, G., Ni, J., Wei, Y.-F., Yu, G.-L., Gentz, R., & Dixit, V. M. (1997) · Science · doi:10.1126/science.277.5327.815 · Cited by 1,496
TNF-α Induces Two Distinct Caspase-8 Activation Pathways
Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,351
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218 · cited 1×
“In addition to blocking the NF- B transcriptional activity, TNF signaling can also be switched from prosurvival to pro-cell death in transformed cells by simultaneous use of a Smac mimetic, a small molecule designed to resemble the N terminus of Smac that interacts with and inhibits XIAP, cIAP-1, and cIAP-2 (110, 142).”
BackgroundBertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,109
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., & Mountz, J. D. (1994) · Science · doi:10.1126/science.7510905 · Cited by 1,107
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., & Schlesinger, P. H. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400783 · Cited by 1,034
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,000
Caspase activation: The induced-proximity model
Salvesen, G. S., & Dixit, V. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.10964 · Cited by 933
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling
Chan, F. K.-M., Chun, H. J., Zheng, L., Siegel, R. M., Bui, K. L., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2351 · Cited by 856
Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 836
Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., & Goodwin, R. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80399-4 · Cited by 821
Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., & Tschopp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1205 · Cited by 812
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2354 · Cited by 662
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Janssen, E. M., Droin, N. M., Lemmens, E. E., Pinkoski, M. J., Bensinger, S. J., Ehst, B. D., Griffith, T. S., Green, D. R., & Schoenberger, S. P. (2005) · Nature · doi:10.1038/nature03337 · Cited by 619
Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1627 · Cited by 612
Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
Scaffidi, C., Schmitz, I., Zha, J., Korsmeyer, S. J., Krammer, P. H., & Peter, M. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22532 · Cited by 580
Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis
Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J., Harran, P., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 571
c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis
Chang, D. W. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf356 · Cited by 563
The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways
Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., et al. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00512-1 · Cited by 552
FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis
Krueger, A., Baumann, S., Krammer, P. H., & Kirchhoff, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8247-8254.2001 · Cited by 549
Inhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Yeh, W.-C., Itie, A., Elia, A. J., Ng, M., Shu, H.-B., Wakeham, A., Mirtsos, C., Suzuki, N., Bonnard, M., Goeddel, D. V., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80214-9 · Cited by 515
Newton, K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.3.706 · Cited by 499
Compartmentalization of TNF Receptor 1 Signaling
Schneider-Brachert, W., Tchikov, V., Neumeyer, J., Jakob, M., Winoto-Morbach, S., Held-Feindt, J., Heinrich, M., Merkel, O., Ehrenschwender, M., Adam, D., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.017 · Cited by 485
The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., & Grütter, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206882200 · Cited by 482
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
Grell, M., Wajant, H., Zimmermann, G., & Scheurich, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.570 · Cited by 478
RIP1, a kinase on the crossroads of a cell's decision to live or die
Festjens, N., Vanden Berghe, T., Cornelis, S., & Vandenabeele, P. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402085 · Cited by 468
Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation
Legler, D. F., Micheau, O., Doucey, M.-A., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 466
Straus, S. E. (2001) · Blood · doi:10.1182/blood.v98.1.194 · Cited by 464
Caspase Activation Is Required for T Cell Proliferation
Kennedy, N. J., Kataoka, T., Tschopp, J., & Budd, R. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1891 · Cited by 459
TRAIL signalling: Decisions between life and death
Falschlehner, C., Emmerich, C. H., Gerlach, B., & Walczak, H. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.007 · Cited by 458
Barnhart, B. C., Alappat, E. C., & Peter, M. E. (2003) · Seminars in Immunology · doi:10.1016/s1044-5323(03)00031-9 · Cited by 419
Cascino, I., Fiucci, G., Papoff, G., & Ruberti, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.6.2706 · Cited by 397
Molecular Ordering of the Initial Signaling Events of CD95
Algeciras-Schimnich, A., Shen, L., Barnhart, B. C., Murmann, A. E., Burkhardt, J. K., & Peter, M. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.207-220.2002 · Cited by 393
Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., & Wallach, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.387 · Cited by 387
The RIP kinases: crucial integrators of cellular stress
Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 382
Nature's TRAIL—On a Path to Cancer Immunotherapy
Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R. M., & Yagita, H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00502-2 · Cited by 366
Transcriptional control of liver regeneration
Taub, R. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.4.8647340 · Cited by 353
Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.06.007 · Cited by 349
MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors
Tran, S. E. F., Holmström, T. H., Ahonen, M., Kähäri, V.-M., & Eriksson, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010384200 · Cited by 330
To kill a tumor cell: the potential of proapoptotic receptor agonists
Ashkenazi, A., & Herbst, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34359 · Cited by 323
Rasper, D. M., Vaillancourt, J. P., Hadano, S., Houtzager, V. M., Seiden, I., Keen, S. L., Tawa, P., Xanthoudakis, S., Nasir, J., Martindale, D., et al. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400370 · Cited by 316
Fas engagement induces neurite growth through ERK activation and p35 upregulation
Desbarats, J., Birge, R. B., Mimouni-Rongy, M., Weinstein, D. E., Palerme, J.-S., & Newell, M. K. (2003) · Nature Cell Biology · doi:10.1038/ncb916 · Cited by 312
Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling
O'Donnell, M. A., Legarda-Addison, D., Skountzos, P., Yeh, W. C., & Ting, A. T. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.027 · Cited by 310
Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
Kleber, S., Sancho-Martinez, I., Wiestler, B., Beisel, A., Gieffers, C., Hill, O., Thiemann, M., Mueller, W., Sykora, J., Kuhn, A., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.003 · Cited by 309
Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2
Mérino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., & Micheau, O. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00520-06 · Cited by 305
Activation of NF-κB by FADD, Casper, and Caspase-8
Hu, W.-H., Johnson, H., & Shu, H.-B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10838 · Cited by 288
Kelley, R. F., Totpal, K., Lindstrom, S. H., Mathieu, M., Billeci, K., DeForge, L., Pai, R., Hymowitz, S. G., & Ashkenazi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410660200 · Cited by 284
CD95 ligand induces motility and invasiveness of apoptosis‐resistant tumor cells
Barnhart, B. C., Legembre, P., Pietras, E., Bubici, C., Franzoso, G., & Peter, M. E. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600325 · Cited by 284
Varfolomeev, E., Maecker, H., Sharp, D., Lawrence, D., Renz, M., Vucic, D., & Ashkenazi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509560200 · Cited by 282
c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 282
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation
Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277
Lee, T. H., Shank, J., Cusson, N., & Kelliher, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404206200 · Cited by 255
Temperature-sensitive Differential Affinity of TRAIL for Its Receptors
Truneh, A., Sharma, S., Silverman, C., Khandekar, S., Reddy, M. P., Deen, K. C., Mclaughlin, M. M., Srinivasula, S. M., Livi, G. P., Marshall, L. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910438199 · Cited by 245
The role of receptor internalization in CD95 signaling
Lee, K., Feig, C., Tchikov, V., Schickel, R., Hallas, C., Schütze, S., Peter, M. E., & Chan, A. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601016 · Cited by 244
Fas engagement accelerates liver regeneration after partial hepatectomy
Desbarats, J., & Newell, M. K. (2000) · Nature Medicine · doi:10.1038/78688 · Cited by 241
Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., & Chan, F. K.-M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507329102 · Cited by 232
FADD Is Required for DR4- and DR5-mediated Apoptosis
Kuang, A. A., Diehl, G. E., Zhang, J., & Winoto, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000284200 · Cited by 232
Hayakawa, Y., Screpanti, V., Yagita, H., Grandien, A., Ljunggren, H.-G., Smyth, M. J., & Chambers, B. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.123 · Cited by 223
Hueber, A., Bernard, A., Hérincs, Z., Couzinet, A., & He, H. (2002) · EMBO reports · doi:10.1093/embo-reports/kvf022 · Cited by 221
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
Trauzold, A., Siegmund, D., Schniewind, B., Sipos, B., Egberts, J., Zorenkov, D., Emme, D., Röder, C., Kalthoff, H., & Wajant, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209719 · Cited by 219
Hu, W.-H., Johnson, H., & Shu, H.-B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30603 · Cited by 219
Ganten, T. M., Koschny, R., Sykora, J., Schulze-Bergkamen, H., Büchler, P., Haas, T. L., Schader, M. B., Untergasser, A., Stremmel, W., & Walczak, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2635 · Cited by 217
Wajant, H., Moosmayer, D., Wüest, T., Bartke, T., Gerlach, E., Schönherr, U., Peters, N., Scheurich, P., & Pfizenmaier, K. (2001) · Oncogene · doi:10.1038/sj.onc.1204558 · Cited by 212
Harper, N., Hughes, M., MacFarlane, M., & Cohen, G. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303399200 · Cited by 211
Mariani, S. M., & Krammer, P. H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<973::aid-immu973>3.0.co;2-t · Cited by 205
Ceramide Formation Leads to Caspase-3 Activation during Hypoxic PC12 Cell Death
Yoshimura, S.-I., Banno, Y., Nakashima, S., Takenaka, K., Sakai, H., Nishimura, Y., Sakai, N., Shimizu, S., Eguchi, Y., Tsujimoto, Y., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6921 · Cited by 203
Signaling by the TNF Receptor Superfamily and T Cell Homeostasis
Chan, F. K.-M., Siegel, R. M., & Lenardo, M. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00041-8 · Cited by 200
Cell death: TRAIL and its receptors
GOLSTEIN, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)90000-1 · Cited by 194
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00072-2 · Cited by 191
Palmitoylation is required for efficient Fas cell death signaling
Chakrabandhu, K., Hérincs, Z., Huault, S., Dost, B., Peng, L., Conchonaud, F., Marguet, D., He, H., & Hueber, A. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601456 · Cited by 190
Grosse-Wilde, A., Voloshanenko, O., Bailey, S. L., Longton, G. M., Schaefer, U., Csernok, A. I., Schütz, G., Greiner, E. F., Kemp, C. J., & Walczak, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33061 · Cited by 190
Tumor necrosis factor receptor-associated factor (TRAF) 2 and its role in TNF signaling
Wajant, H., & Scheurich, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00064-9 · Cited by 184
Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells
Ishimura, N., Isomoto, H., Bronk, S. F., & Gores, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00242.2005 · Cited by 183
Self-citationCysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL
Bodmer, J.-L., Meier, P. F., Tschopp, J., & Schneider, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909721199 · Cited by 182
TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
Finnberg, N., Klein-Szanto, A. J. P., & El-Deiry, W. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci29900 · Cited by 180
Feig, C., Tchikov, V., Schütze, S., & Peter, M. E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601460 · Cited by 160
Wajant, H. (2003) · Essays in Biochemistry · doi:10.1042/bse0390053 · Cited by 149
Siegel, R. M., Muppidi, J. R., Sarker, M., Lobito, A. A., Jen, M. V., Martin, D., Straus, S. E., & Lenardo, M. J. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406101 · Cited by 147
Devin, A., Lin, Y., & Liu, Z. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor854 · Cited by 143
Defining CD95 as a tumor suppressor gene
Müschen, M., Warskulat, U., & Beckmann, M. W. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000112 · Cited by 139
TRAIL: a multifunctional cytokine
Schaefer, U., Voloshanenko, O., Willen, D., & Walczak, H. (2007) · Frontiers in bioscience · doi:10.2741/2354 · Cited by 138
Chao, Y., Shiozaki, E. N., Srinivasula, S. M., Rigotti, D. J., Fairman, R., & Shi, Y. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030183 · Cited by 134
Kohlhaas, S. L., Craxton, A., Sun, X.-M., Pinkoski, M. J., & Cohen, G. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700438200 · Cited by 130
Caspase-10 Triggers Bid Cleavage and Caspase Cascade Activation in FasL-induced Apoptosis
Milhas, D., Cuvillier, O., Therville, N., Clavé, P., Thomsen, M., Levade, T., Benoist, H., & Ségui, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414358200 · Cited by 128
Kim, Y. S., Schwabe, R. F., Qian, T., Lemasters, J. J., & Brenner, D. A. (2002) · Hepatology · doi:10.1002/hep.1840360627 · Cited by 119
PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy
Jackson, L. N., Larson, S. D., Silva, S. R., Rychahou, P. G., Chen, L. A., Qiu, S., Rajaraman, S., & Evers, B. M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00062.2008 · Cited by 116
TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
Riccioni, R., Pasquini, L., Mariani, G., Saulle, E., Rossini, A., Diverio, D., Pelosi, E., Vitale, A., Chierichini, A., Cedrone, M., et al. (2005) · PubMed · Cited by 110
Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism
Schneider‐Brachert, W., Tchikov, V., Merkel, O., Jakob, M., Hallas, C., Kruse, M., Groitl, P., Lehn, A., Hildt, E., Held‐Feindt, J., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23771 · Cited by 108
Induction of apoptosis and activation of NF‐κB by CD95 require different signalling thresholds
Legembre, P., Barnhart, B. C., Zheng, L., Vijayan, S., Straus, S. E., Puck, J. M., Dale, J. K., Lenardo, M. J., & Peter, M. E. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400280 · Cited by 108
Henkler, F., Behrle, E., Dennehy, K. M., Wicovsky, A., Peters, N., Warnke, C., Pfizenmaier, K., & Wajant, H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501048 · Cited by 104
Does CD95 have tumor promoting activities?
Peter, M. E., Legembre, P., & Barnhart, B. C. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.01.001 · Cited by 103
Eramo, A., Sargiacomo, M., Ricci‐Vitiani, L., Todaro, M., Stassi, G., Messina, C. G. M., Parolini, I., Lotti, F., Sette, G., Peschle, C., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324786 · Cited by 103
Tzung, S.-P., Fausto, N., & Hockenbery, D. M. (1997) · PubMed · Cited by 102
Shudo, K., Ryu, I., & Shigekazu, N. (2003) · Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University) · Cited by 89
Söderström, T., Poukkula, M., Holmström, T. H., Heiskanen, K. M., & Eriksson, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2851 · Cited by 88
Gores, G., & Kaufmann, S. H. (2001) · Hepatology · doi:10.1053/jhep.2001.25173 · Cited by 88
Self-citationHong, F., Nguyen, V.-A., Shen, X., Kunos, G., & Gao, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4044 · Cited by 86
Expression ofTRAILand Its Receptors in Human Brain Tumors
Stephan, F., Köhler, U., Schackert, G., & Schackert, H. K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0493 · Cited by 82
Koyama, S., Koike, N., & Adachi, S. (2002) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320100292 · Cited by 76
Cutting Edge: Modulation of Fas-Mediated Apoptosis by Lipid Rafts in T Lymphocytes
Legembre, P., Daburon, S., Moreau, P., Moreau, J., & Taupin, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.716 · Cited by 75
Evidence for a Proangiogenic Activity of TNF-Related Apoptosis-Inducing Ligand
Secchiero, P., Gonelli, A., Carnevale, E., Corallini, F., Rizzardi, C., Zacchigna, S., Melato, M., & Zauli, G. (2004) · Neoplasia · doi:10.1593/neo.03421 · Cited by 73
Lee, T.-J., Lee, J. T., Park, J., & Kwon, T. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.163 · Cited by 72
Chakrabandhu, K., Huault, S., Garmy, N., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.115 · Cited by 67
Leverkus, M., Sprick, M. R., Wachter, T., Denk, A., Bröcker, E., Walczak, H., & Neumann, M. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12332.x · Cited by 65
Lancaster, J. M., Sayer, R. A., Blanchette, C., Calingaert, B., Whitaker, R. S., Schildkraut, J., Marks, J. R., & Berchuck, A. (2003) · PubMed · Cited by 60
Human astrocytic brain tumors express APO2L/TRAIL
Rieger, J., Ohgaki, H., Kleihues, P., & Weller, M. (1999) · Acta Neuropathologica · doi:10.1007/s004010050948 · Cited by 59
Lavrik, I. N., Mock, T., Golks, A., Hoffmann, J. C., Baumann, S., & Krammer, P. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800823200 · Cited by 59
Guicciardi, M. E., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00497.2006 · Cited by 55
Self-citationCD95 Ligand Is a Proliferative and Antiapoptotic Signal in Quiescent Hepatic Stellate Cells
Reinehr, R., Sommerfeld, A., & Häussinger, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.021 · Cited by 52
Actin dependent CD95 internalization is specific for Type I cells
Algeciras-Schimnich, A., & Peter, M. E. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00558-1 · Cited by 46
Neumeyer, J., Hallas, C., Merkel, O., Winoto‐Morbach, S., Jakob, M., Thon, L., Adam, D., Schneider‐Brachert, W., & Schütze, S. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.03.014 · Cited by 45
Dohrman, A., Russell, J. Q., Cuenin, S., Fortner, K. A., Tschopp, J., & Budd, R. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.311 · Cited by 45
Functional expression of TRAIL by lymphoid and myeloid tumour cells
Zhao, S., Asgari, Z., Wang, Y., Goodwin, R. G., Andreeff, M., & Younes, A. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01630.x · Cited by 41
Kim, Y.-S. (2002) · Hepatology · doi:10.1053/jhep.2002.36942 · Cited by 32
Zhao, Y., Lajoie, G., Zhang, H., Chiu, B., Payne, U., & Inman, R. D. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1243-1251.2000 · Cited by 31
Große-Wilde, A., & Kemp, C. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0078 · Cited by 30
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Pistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Natural Killer Cells: Development, Maturation, and Clinical Utilization
Abel, A. M., Yang, C., Thakar, M. S., & Malarkannan, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01869 · Cited by 1,150
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
Retracted
Metadata
- Authors
- Guicciardi, M. E., & Gores, G. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-01-13
- Volume
- 23
- Issue
- 6
- Pages
- 1625-1637
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1971411560
- Cited by
- 690
- References
- 142
- FWCI
- 15.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.